Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Devine

Showing results (111-120 of 178) with videos related to

Pageof 18
Sort By:
Blood|April 13, 2013
MicroRNAs activate natural killer cells through Toll-like receptor signalingShun He, Jianhong Chu, Lai-Chu Wu, et al.
Transplantation and Cellular Therapy|April 18, 2021
The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 PandemicJack W Hsu, Nosha Farhadfar, Hemant Murthy, et al.
Stem Cells Translational Medicine|September 10, 2017
Safety Profile of Good Manufacturing Practice Manufactured Interferon γ-Primed Mesenchymal Stem/Stromal Cells for Clinical TrialsAdam J Guess, Beth Daneault, Rongzhang Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201Edmund K Waller, Brent R Logan, Wayne A C Harris, et al.
Blood|January 31, 2013
Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?Amin M Alousi, Jennifer Le-Rademacher, Rima M Saliba, et al.
Leukemia & Lymphoma|September 13, 2014
A phase 1 study of vorinostat maintenance after autologous transplant in high-risk lymphomaCraig C Hofmeister, Nita Williams, Susan Geyer, et al.
Blood Advances|June 24, 2025
Up-front alternative donor HCT in severe aplastic anemia: gaps and opportunities to translate evidence into practiceNeel S Bhatt, Azra Borogovac, Yvonne A Efebera, et al.
Neurology|February 3, 2017
High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MSRichard A Nash, George J Hutton, Michael K Racke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2010
Dose escalation of lenalidomide in relapsed or refractory acute leukemiasWilliam Blum, Rebecca B Klisovic, Heiko Becker, et al.
Blood|October 2, 2013
Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantationChristopher Bredeson, Jennifer LeRademacher, Kazunobu Kato, et al.
Pageof 18

Showing results (111-120 of 178) with videos related to

Sort By:
Pageof 18
Blood|April 13, 2013
MicroRNAs activate natural killer cells through Toll-like receptor signalingShun He, Jianhong Chu, Lai-Chu Wu, et al.
Transplantation and Cellular Therapy|April 18, 2021
The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 PandemicJack W Hsu, Nosha Farhadfar, Hemant Murthy, et al.
Stem Cells Translational Medicine|September 10, 2017
Safety Profile of Good Manufacturing Practice Manufactured Interferon γ-Primed Mesenchymal Stem/Stromal Cells for Clinical TrialsAdam J Guess, Beth Daneault, Rongzhang Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201Edmund K Waller, Brent R Logan, Wayne A C Harris, et al.
Blood|January 31, 2013
Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?Amin M Alousi, Jennifer Le-Rademacher, Rima M Saliba, et al.
Leukemia & Lymphoma|September 13, 2014
A phase 1 study of vorinostat maintenance after autologous transplant in high-risk lymphomaCraig C Hofmeister, Nita Williams, Susan Geyer, et al.
Blood Advances|June 24, 2025
Up-front alternative donor HCT in severe aplastic anemia: gaps and opportunities to translate evidence into practiceNeel S Bhatt, Azra Borogovac, Yvonne A Efebera, et al.
Neurology|February 3, 2017
High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MSRichard A Nash, George J Hutton, Michael K Racke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2010
Dose escalation of lenalidomide in relapsed or refractory acute leukemiasWilliam Blum, Rebecca B Klisovic, Heiko Becker, et al.
Blood|October 2, 2013
Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantationChristopher Bredeson, Jennifer LeRademacher, Kazunobu Kato, et al.
Pageof 18